PLA2G7 and type 2 diabetes mellitus: The purpose of this randomized, double-blind, placebo-controlled clinical trial was to examine the effect of multi-strain probiotic supplementation on Lp-PLA2 as the primary biomarker, as well as glycemic parameters, lipid profile, body composition, and anthropometrics in patients with T2D.